Perfusion abnormalities in prodromal AD

被引:103
作者
Johnson, KA
Albert, MS
机构
[1] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
Alzheimer; SPECT; PET; perfusion; radionuclide imaging; dementia;
D O I
10.1016/S0197-4580(00)00137-8
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Cerebral perfusion abnormalities in patients with established Alzheimer's disease (AD) are most commonly seen in the temporoparietal cortex. As the disease progresses, this perfusion pattern is increasingly prevalent. Recently, investigators have begun to examine the patterns of perfusion among individuals at risk for AD. To date, such studies have been conducted either in individuals who have a progressive memory difficulty but do not yet meet clinical criteria for AD, or in individuals with a genetic risk factor or family history of AD, either with or without a memory problem. These latter studies suggest that a set of brain regions show decreased perfusion during the prodromal phase of AD, and that a brain network or networks with multiple nodes is affected early in the course of AD. These perfusion abnormalities may also shed light on how AD progresses during the prodromal phase of disease and may ultimately lead to improved diagnosis or methods of monitoring response to treatment. (C) 2000 Published by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:289 / 292
页数:4
相关论文
共 43 条
[1]  
ALBERT M, UNPUB PRECLINICAL PR
[2]   IPSILATERAL CONNECTIONS OF THE ANTERIOR CINGULATE CORTEX WITH THE FRONTAL AND MEDIAL TEMPORAL CORTICES IN THE MACAQUE MONKEY [J].
ARIKUNI, T ;
SAKO, H ;
MURATA, A .
NEUROSCIENCE RESEARCH, 1994, 21 (01) :19-39
[3]   NEURONAL LOSS, NEUROFIBRILLARY TANGLES AND GRANULOVACUOLAR DEGENERATION IN HIPPOCAMPUS WITH AGING AND DEMENTIA - QUANTITATIVE STUDY [J].
BALL, MJ .
ACTA NEUROPATHOLOGICA, 1977, 37 (02) :111-118
[4]   No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes [J].
Corder, EH ;
Jelic, V ;
Basun, H ;
Lannfelt, L ;
Valind, S ;
Winblad, B ;
Nordberg, A .
ARCHIVES OF NEUROLOGY, 1997, 54 (03) :273-277
[5]  
DALY E, IN PRESS ARCH NEUROL
[6]  
DEKOSKY S T, 1990, Alzheimer Disease and Associated Disorders, V4, P14, DOI 10.1097/00002093-199040100-00002
[7]   POSITRON EMISSION TOMOGRAPHY IN ALZHEIMERS-DISEASE [J].
DUARA, R ;
GRADY, C ;
HAXBY, J ;
SUNDARAM, M ;
CUTLER, NR ;
HESTON, L ;
MOORE, A ;
SCHLAGETER, N ;
LARSON, S ;
RAPOPORT, SI .
NEUROLOGY, 1986, 36 (07) :879-887
[8]  
FARKAS T, 1982, AM J PSYCHIAT, V139, P352
[9]   CORTICAL ABNORMALITIES IN ALZHEIMERS-DISEASE [J].
FOSTER, NL ;
CHASE, TN ;
MANSI, L ;
BROOKS, R ;
FEDIO, P ;
PATRONAS, NJ ;
DICHIRO, G .
ANNALS OF NEUROLOGY, 1984, 16 (06) :649-654
[10]   REGIONAL CEREBRAL METABOLIC ALTERATIONS IN DEMENTIA OF THE ALZHEIMER TYPE - POSITRON EMISSION TOMOGRAPHY WITH [FLUORODEOXYGLUCOSE-F-18 [J].
FRIEDLAND, RP ;
BUDINGER, TF ;
GANZ, E ;
YANO, Y ;
MATHIS, CA ;
KOSS, B ;
OBER, BA ;
HUESMAN, RH ;
DERENZO, SE .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1983, 7 (04) :590-598